Personal
Become a Client
Amgen Inc (USD)
AMGN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range245.81 | 249.10
52-Wk Range- | -
Last Close248.95
Mkt Cap (m)143,346.03
Dividend yield2.64
ISINUS0311621009
Volume1,368,801.00
Exchange VenueNAS

Company Profile

Amgen Inc is a U.S. based biotechnology company, with historical expertise in renal disease and cancer supportive care products. The firm discovers, develops, manufactures and delivers human therapeutics.

Key Information
Price/Earning20.22
Price/Book15.24
Price/Sales5.78
P/CF13.99
Rev Growth (3 year avg)3.62
EPS Growth (3 year avg)0.66
Operating Margin % 35.95
Net Margin %28.57
Return on Equity76.13
Debt/Equity3.51

Documents

Prospectus
en 06/05/2020
Annual Report
en 31/12/2020

Please refer to the below issuer website for further documents.

https://www.amgen.com

Financials

Income Statement
USD201520162017201820192020
Revenue (m)21,662.0022,991.0022,849.0023,747.0023,362.0025,424.00
Operating Income (m)8,470.009,794.009,973.0010,263.009,674.009,139.00
Net Income (m)6,939.007,722.001,979.008,394.007,842.007,264.00
Basic EPS9.1510.322.7112.7012.9612.40
Avg. Diluted Shares Outstanding (m)766.00754.00735.00665.00609.00590.00
Balance Sheet
USD201520162017201820192020
Current Assets (m)38,518.0046,010.0049,476.0037,618.0018,440.0021,144.00
Non Current Assets (m)33,058.0031,616.0030,478.0028,798.0041,267.0041,804.00
Total Assets (m)71,576.0077,626.0079,954.0066,416.0059,707.0062,948.00
Current Liabilities (m)8,667.0011,204.009,020.0013,488.0012,835.0011,653.00
Total Liabilities (m)------
Total Equity (m)28,083.0029,875.0025,241.0012,500.009,673.009,409.00
Cash Flows
USD201520162017201820192020
Operating Cash Flows (m)9,077.0010,354.0011,177.0011,296.009,150.0010,497.00
Capital Expenditure (m)-649.00-837.00-664.00-738.00-618.00-608.00
Figures are quoted in USD unless stated otherwise
-
No change
$
248.95
Last Price